RTI Biologics, Inc. (RTIX)

[surf1944]

8:01AM RTI Biologics beats by $0.01, beats on revs; guides Q3 EPS in-line, revs above consensus; guides FY11 EPS above consensus, revs above consensus (RTIX) 2.98 : Reports Q2 (Jun) earnings of $0.04 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.03; revenues rose 5.8% year/year to $43.5 mln vs the $40.5 mln consensus. Co issues mixed guidance for Q3, sees EPS of $0.03 vs. $0.03 Capital IQ Consensus Estimate; sees Q3 revs of $40-41 mln vs. $39.01 mln Capital IQ Consensus Estimate. Co issues upside guidance for FY11, sees EPS of $0.12-0.14 vs. $0.12 Capital IQ Consensus Estimate; sees FY11 revs of $164-166 mln vs. $161.82 mln Capital IQ Consensus Estimate.